Clinical Trial: A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India

U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07685769) titled 'A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India' on June 29.

Brief Summary: This is a multicenter, single-arm, open-label Phase 4 study evaluating the safety and tolerability of rimegepant 75 mg orally disintegrating tablet (ODT) for the acute treatment of migraine (with or without aura) in adult patients in India who have had an insufficient response, intolerance, or contraindication to triptans. It will enroll approximately 60 participants.

Study Start Date: July 17

Study Type: INTERVENTIONAL

Condition: Acute Treatment of Migraine

Intervention: DRUG: Rimegepant 75 mg ODT

Rimegepant 75 mg ODT...